Status Relations and Associations in Life Science Venturing

Alexander Styhre ()
Additional contact information
Alexander Styhre: University of Gothenburg

Chapter Chapter 6 in Status and Organizations, 2022, pp 145-166 from Springer

Abstract: Abstract This chapter discusses how a high-status pharmaceutical company’s business incubator generate positive effects for life science companies re-locating to the incubator. Life science companies in a development phase are frequently undercapitalized, i.e., they need raise new funds to finance the development work on several occasions. If being affiliated with a major market actor, life science companies may benefit from lower thresholds when raising venture capital as finance capital investors regard the inclusion in the incubator as indicative of the market potential of the company. The status of the company managing the incubator, including the selection of firms to include, signal to venture capital investors that these companies have qualities that make them attractive investment objects.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-09868-0_6

Ordering information: This item can be ordered from
http://www.springer.com/9783031098680

DOI: 10.1007/978-3-031-09868-0_6

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().